Kano Therapeutics
Contact
Links
View in org chart
Floris Engelhardt
Co-founder & CEO
Scott Hamilton
Director, CMC
John Vroom
Chief Business Officer & Co-founder
Greg Foley
Associate Director, Synthetic Biology
Mark Bathe
Co-founder
Steph Barr
Senior Research Associate
Beaven Ankner - Edelstein
Research Associate
Jared Eller
Scientist, Process Development
February, 2024 - present